Trial · NCT04518293
Outcomes40
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 40
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Difference in Change in Home Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Clinic Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Clinic Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Clinic Seated Mean Diastolic Blood Pressure (DBP) From Randomization to Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Clinic Seated Mean Diastolic Blood Pressure (DBP) From Randomization to Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Participants With Clinic Seated Mean Systolic Blood Pressure (SBP) <140 and Diastolic Blood Pressure (DBP) <90 mmHg at Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Clinic Seated Mean Systolic Blood Pressure (SBP) <140 and Diastolic Blood Pressure (DBP) <90 mmHg at Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Clinic Seated Mean Systolic Blood Pressure (SBP) <130 and Diastolic Blood Pressure (DBP) <80 mmHg at Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Clinic Seated Mean Systolic Blood Pressure (SBP) <130 and Diastolic Blood Pressure (DBP) <80 mmHg at Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Difference in Change in Home Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Home Seated Mean Diastolic Blood Pressure (DBP) From Randomization to Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Home Seated Mean Diastolic Blood Pressure (DBP) From Randomization to Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Trough Home Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Difference in Change in Trough Home Seated Mean Systolic Blood Pressure (SBP) From Randomization to Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | mmHg | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Participants With Home Seated Mean Systolic Blood Pressure (SBP) <135 and Diastolic Blood Pressure (DBP) <85 mmHg at Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Home Seated Mean Systolic Blood Pressure (SBP) <135 and Diastolic Blood Pressure (DBP) <85 mmHg at Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Home Seated Mean Systolic Blood Pressure (SBP) <130 and Diastolic Blood Pressure (DBP) <80 mmHg at Week 12 | Week 12 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants With Home Seated Mean Systolic Blood Pressure (SBP) <130 and Diastolic Blood Pressure (DBP) <80 mmHg at Week 6 | Week 6 | Analysis was performed on all participants who had been randomized. Participants were analyzed in the treatment group to which they had been randomized. | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Percentage of Participants Discontinued Trial Medication Due to Adverse Event (AE)/Serious Adverse Event (SAE) From Randomization to Week 12 | Week 12 | Analysis was done on the safety set which included all participants who had taken at least one dose of study treatment, including during Period 1 single-blind run-in. For the analysis of the safety outcomes, participants were analyzed in the treatment group that was received. | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Percentage of Participants Discontinued Trial Medication Due to Adverse Event (AE)/Serious Adverse Event (SAE) From Randomization to Week 6 | Week 6 | Analysis was done on the safety set which included all participants who had taken at least one dose of study treatment, including during Period 1 single-blind run-in. For the analysis of the safety outcomes, participants were analyzed in the treatment group that was received. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04518293/outcomes